Who hasn't been there? The big meal is over, you're full, but the craving for sweets remains. Researchers from the Max Planck ...

Nerve cells called pro-opiomelanocortin (POMC) neurons were found to be responsible for post-feeding sugar consumption.

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...

Doctors from the Cleveland Clinic talk about how this new non-opioid pain medication could help reduce the issue of opioid ...

Every year, thousands of people die from overdosing on opioids in the United States. But a new non-opioid pain medication, ...

The Food and Drug Administration (FDA) is hoping a newly approved non-opioid pain medication could help save lives. Dr.

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

The Phase IIa results continue a surge of momentum in a treatment space that last week saw the approval of Vertex’s Journavx ...

Experts with the Cleveland Clinic say the drug has a lot of potential, especially since it is considered nonaddictive.

More than 81,000 people in 2023 died in overdoses that involved opioids, according to federal data. According to the FDA, Journavx “reduces pain by targeting a pain-signaling pathway involving ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.

FDA Approves Non-Opioid Treatment for Moderate to Severe Acute Pain as Agency Continues to Take Steps to Support New ...